我不太主张减少免疫抑制性药物的使用，因为会出现移植排斥的危险。
I would not recommend scaling down the use of immunosuppressants because there is always the danger of graft rejection.
Geron公司这类临床试验将仅需要临时使用低剂量的免疫抑制性药物。
Geron said its trial would require only temporary use of low doses of immune-suppressing drugs.
结论：盼生安是周期特异性药物，通过将细胞阻滞于G1/G0 期而抑制其增殖。
CONCLUSIONS:Panshengan is a cell cycle-specific drug which can arrest the cells at G1/G0 phase.
应用推荐